Our results have demonstrated that H19/miR-675 and LNC000093 from leukemic cells are transported through extracellular vesicle exosomes and exert effects on BMSCs to alter the expression of VEGF, which is a representative promoter of tumor angiogenesis and is associated drug resistance (Fan et al., 2012; Finley and Popel, 2013). The gene discussed is VEGFA; the disease is neoplasm.